Table 1.
Baseline characteristics of the overall study population.
| Characteristic | Value |
|---|---|
| Demographics | |
| Age, yr, mean ± SD | 67.9 ± 9.2 |
| Sex, male, n (%) | 110 (60.8) |
| Medical history | |
| Hypertension, n (%) | 122 (67.4) |
| Diabetes mellitus, n (%) | 51 (28.2) |
| Dyslipidemia, n (%) | 65 (35.9) |
| Atrial fibrillation, n (%) | 53 (29.3) |
| Clinical presentation | |
| Baseline NIHSS score, mean ± SD | 9.7 ± 4.4 |
| Onset-to-needle time, min, mean ± SD | 142.4 ± 36.9 |
| Imaging | |
| ASPECTS score, mean ± SD | 7.9 ± 1.2 |
| Basic laboratory values | |
| WBC, ×109/L, mean ± SD | 8.6 ± 2.5 |
| Hemoglobin, g/L, mean ± SD | 134 ± 13 |
| Platelets, ×109/L, mean ± SD | 232 ± 52 |
ASPECTS = Alberta Stroke Program Early CT Score, NIHSS = National Institutes of Health Stroke Scale, SD = standard deviation, WBC = white blood cell.